目的了解酒精性肝硬变的治疗与转归。
Objective To understand the treatment of alcoholic cirrhosis.
目的建立稳定的肝硬变门脉高压症模型。
Objective to establish the reliable model of hepatocirrhosis with portal hypertension.
目的：观察蜂实饮治疗肝硬变腹水的疗效。
Objective: To analyze clinical effect of Fengshi decoction on liver cirrhotic ascites.
结论：蜂实饮治疗肝硬变腹水有较好的疗效。
Conclusions: Fengshi decoction has a definite effect on liver cirrhotic ascites.
典型的病人有明显的晚期营养性肝硬变的体症。
The typical patient has obvious signs of advanced nutritional cirrhosis.
目的探讨肝移植对肝硬变大鼠脾脏功能的影响。
Objective To investigate the effects of liver transplantation on splenic function in rats with hepatic cirrhosis.
肝移植治疗一例胆汁性肝硬变，硬化性胆管炎。
A cases with biliary cirrhosis and sclerotic cholangitis underwent the liver transplantation.
目的探讨肝硬变患者血清中微量元素含量的变化。
Objective To study the change of serum trace elements in patients with liver cirrhosis.
目的探讨肝细胞凋亡与肝硬变及原癌基因的关系。
To study the relationship of hepatocyte apoptosis and gene expression of liver cirrhosis and primary hepatic carcinoma.
肝硬变治疗后显效者肝血流量较治疗前下降明显。
The liver blood reduced obviously compared with that before treatment.
目的：探讨脾切除对肝硬变大鼠移植型肝癌的影响。
Objective: to study the effects of splenectomy on the growth of intrahepatic implanted hepatoma in the rats with cirrhosis.
目的：探讨肝硬变顽固性腹水的治疗及影响疗效的因素。
Aim: to investigate the therapeutic effect of intractable ascites of cirrhosis and closely related factors.
目的探讨继发性胆汁性肝硬变门脉高压症的诊断和治疗。
Objective To study the diagnosis and treatment of portal hypertension in secondary biliary cirrhosis(PHSBC).
目的：分析肝硬变患者糖代谢异常与中医辨证分型的关系。
Objective: to analyze the relationship of hepatocirrhosis patients' glycometabolism disorder and syndrome differentiating of TCM.
方法收集我院肝硬变腹水住院病人病历680份，逐份分析。
Methods Data of cases of liver cirrhosis with ascites hospitalized in our institute were collected in 680 and studied one by one.
这些转录体在某些隐源性肝硬变和丙型肝炎患者血清中也存在。
They were also observed in sera from patients with cryptogenic cirrhosis or chronic hepatitis c.
在非肝硬变对照组患者中，肝门静脉灌注明显好于肝硬变患者。
As perfusion of portal vein to liver was concerned, it was significantly better in the control group than in those who suffered from liver cirrhosis.
结果肝硬变患者肝组织内的凋亡细胞及凋亡指数高于正常人；
Results The number of apoptotic cells and the apoptotic index of cirrhotic liver tissue was higher than that of normal subjects.
前言：目的：探讨营养支持在肝硬变合并上消化道出血中的意义。
Objective: To assess the effects of nutrition support in patients with cirrhosis after bleeding from upper gastrointestinal tract.
目的探讨肝炎后肝硬变肝脏体积变化与其病变严重程度间的关系。
Objective To explore the correlation between liver volume variation of posthepatitic cirrhosis patients and the severity of the disease.
观察人工感染日本血吸虫的家兔肝硬变过程中的组织化学动态改变。
The histochemical alterations in liver cirrhosis of the rabbits with experimental schistosomiasis japonica is reported.
目的观察腹水超滤浓缩腹腔回输治疗肝硬变顽固性腹水的疗效与安全性。
Objective To observe the efficacy and safety of ultrafiltration and peritoneal reinfusion of ascites to treat refractory cirrhotic ascites.
目的探讨在门静脉转流条件下肝硬变大鼠耐受入肝血流阻断的安全时限。
Objective To study the effect of portal vein blood bypass(PBB) on the tolerance limit of rats with liver cirrhosis to hepatic inflow occlusion(HIO).
原发性腹膜炎是肝硬变腹水的严重并发症，多见于有严重肝病背景的病人。
Primary peritonitis(PP) is a serious complication of cirrhotic ascites, arising most frenquently in patients with advanced liver disease.
结论肝硬变患者血浆内毒素及一氧化氮水平皆升高，且两者呈直线正相关。
CONCLUSION The plasma levels of endotoxin and nitric oxide in cirrhotic patients were high and positively correlated.
目的：探讨肝硬变并发自发性细菌性腹膜炎(sbp)的诊断、治疗及预防。
Aim: To explore the diagnosis, therapy and prevention of the SBP with liver cirrhosis.
目的比较肝硬变病人不同方法治疗前后，肝血流量与肝纤维化等项指标的改变。
Objective to compare the changes of liver blood flow and liver fibrosis in patients with hepatocirrhosis by ant I fibrosis treatment.
结论：血清透明质酸水平对肝硬变的诊断预后判断和病情监测有良好的参考价值。
Conclusion: The levels of serum HA could be used for prognostic judgement and illness monitoring of hepatic cirrhosis.
结论：血清透明质酸水平对肝硬变的诊断预后判断和病情监测有良好的参考价值。
Conclusion: The levels of serum HA could be used for prognostic judgement and illness monitoring of hepatic cirrhosis.
应用推荐